Last edition
News about "Viwit Pharmaceuticals "
Zydus Signs Licensing and Supply Agreement with Viwit Pharmaceuticals
As per the terms of the agreement, Viwit will be responsible for ANDA submission, manufacturing and supplying the generic versions of GADAVISTTM and DOTAREM, following the receipt of requisite regulatory approval.
Viwit Pharmaceuticals | 16/09/2024 | By Aishwarya | 114
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members